Specialty Pharmaceuticals Market 2028 By Route of Administration, Therapeutic Area, Distribution Channel | The Insight Partners

Specialty Pharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Route of Administration (Oral, Parenteral, Transdermal); Therapeutic Area (Oncology, Inflammatory Conditions, Multiple sclerosis, Growth Hormone, Other Disease Conditions); Distribution Channel (Hospitals, Retail Pharmacies, Specialty Pharmacies, Mail Order)

Report Code: TIPRE00021699 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET INTRODUCTION

Drug molecules that help treat specific genetic conditions that don't have any therapeutic intervention in the market are acknowledged specialty pharmaceuticals. Specialty Pharmaceuticals are more targeted drugs and have less toxicity when associated with conventional medications. Specialty pharmaceuticals include biopharmaceuticals, blood-derived products, and complex molecules. Pharmaceuticals that are having high cost also falls under the specialty pharmaceuticals.

MARKET DYNAMICS

The specialty pharmaceuticals market is driving due to fast-track development of new pharmaceutical industries, major merges and acquisitions among pharmacies, and improvement in pharmacy benefit management (PBM) and healthcare plans. However, the high cost of specialty pharmaceuticals will hamper its growth. Moreover, a high buying power and reimbursement for the specialty pharmaceuticals are expected to provide opportunities in the global specialty pharmaceuticals market.

MARKET SCOPE

The "Specialty Pharmaceuticals Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of specialty pharmaceuticals market with detailed market segmentation by type and end user. The specialty pharmaceuticals market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in specialty pharmaceuticals market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The specialty pharmaceuticals market is segmented based on route of administration, therapeutic area, and distribution channel. Based on route of administration, the market is segmented into oral, parenteral, transdermal. Based on therapeutic area, the market is segmented into oncology, inflammatory conditions, multiple sclerosis, growth hormone, other disease conditions. Based on distribution channel, the market is segmented as hospitals, retail pharmacies, specialty pharmacies, mail order.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Specialty pharmaceuticals market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Specialty pharmaceuticals market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Specialty pharmaceuticals market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the Specialty pharmaceuticals market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Specialty pharmaceuticals market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Specialty pharmaceuticals market are anticipated to have lucrative growth opportunities in the future with the rising demand for Specialty pharmaceuticals in the global market. Below mentioned is the list of few companies engaged in the Specialty pharmaceuticals market.

The report also includes the profiles of key players in Specialty pharmaceuticals market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Pfizer Inc.
  •   Amgen Inc.
  •   AstraZeneca
  •   Teva Pharmaceutical Industries Ltd.
  •   Otsuka America Pharmaceutical, Inc.
  •   rEVO Biologics, Inc.
  •   AbbVie Inc.
  •   Gilead
  •   Janssen Global Services, LLC
  •   Celgene

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Specialty Pharmaceuticals Market - By Route of Administration
1.3.2 Specialty Pharmaceuticals Market - By Therapeutic Area
1.3.3 Specialty Pharmaceuticals Market - By Distribution Channel
1.3.4 Specialty Pharmaceuticals Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SPECIALTY PHARMACEUTICALS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SPECIALTY PHARMACEUTICALS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SPECIALTY PHARMACEUTICALS MARKET - GLOBAL MARKET ANALYSIS
6.1. SPECIALTY PHARMACEUTICALS - GLOBAL MARKET OVERVIEW
6.2. SPECIALTY PHARMACEUTICALS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SPECIALTY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
7.1. OVERVIEW
7.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
7.3. ORAL
7.3.1. Overview
7.3.2. Oral Market Forecast and Analysis
7.4. PARENTERAL
7.4.1. Overview
7.4.2. Parenteral Market Forecast and Analysis
7.5. TRANSDERMAL
7.5.1. Overview
7.5.2. Transdermal Market Forecast and Analysis
8. SPECIALTY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - THERAPEUTIC AREA
8.1. OVERVIEW
8.2. THERAPEUTIC AREA MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. Oncology Market Forecast and Analysis
8.4. INFLAMMATORY CONDITIONS
8.4.1. Overview
8.4.2. Inflammatory Conditions Market Forecast and Analysis
8.5. MULTIPLE SCLEROSIS
8.5.1. Overview
8.5.2. Multiple sclerosis Market Forecast and Analysis
8.6. GROWTH HORMONE
8.6.1. Overview
8.6.2. Growth Hormone Market Forecast and Analysis
8.7. OTHER DISEASE CONDITIONS
8.7.1. Overview
8.7.2. Other Disease Conditions Market Forecast and Analysis
9. SPECIALTY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. SPECIALTY PHARMACIES
9.5.1. Overview
9.5.2. Specialty Pharmacies Market Forecast and Analysis
9.6. MAIL ORDER
9.6.1. Overview
9.6.2. Mail Order Market Forecast and Analysis
10. SPECIALTY PHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Specialty Pharmaceuticals Market Overview
10.1.2 North America Specialty Pharmaceuticals Market Forecasts and Analysis
10.1.3 North America Specialty Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
10.1.4 North America Specialty Pharmaceuticals Market Forecasts and Analysis - By Therapeutic Area
10.1.5 North America Specialty Pharmaceuticals Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Specialty Pharmaceuticals Market Forecasts and Analysis - By Countries
10.1.6.1 United States Specialty Pharmaceuticals Market
10.1.6.1.1 United States Specialty Pharmaceuticals Market by Route of Administration
10.1.6.1.2 United States Specialty Pharmaceuticals Market by Therapeutic Area
10.1.6.1.3 United States Specialty Pharmaceuticals Market by Distribution Channel
10.1.6.2 Canada Specialty Pharmaceuticals Market
10.1.6.2.1 Canada Specialty Pharmaceuticals Market by Route of Administration
10.1.6.2.2 Canada Specialty Pharmaceuticals Market by Therapeutic Area
10.1.6.2.3 Canada Specialty Pharmaceuticals Market by Distribution Channel
10.1.6.3 Mexico Specialty Pharmaceuticals Market
10.1.6.3.1 Mexico Specialty Pharmaceuticals Market by Route of Administration
10.1.6.3.2 Mexico Specialty Pharmaceuticals Market by Therapeutic Area
10.1.6.3.3 Mexico Specialty Pharmaceuticals Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Specialty Pharmaceuticals Market Overview
10.2.2 Europe Specialty Pharmaceuticals Market Forecasts and Analysis
10.2.3 Europe Specialty Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
10.2.4 Europe Specialty Pharmaceuticals Market Forecasts and Analysis - By Therapeutic Area
10.2.5 Europe Specialty Pharmaceuticals Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Specialty Pharmaceuticals Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Specialty Pharmaceuticals Market
10.2.6.1.1 Germany Specialty Pharmaceuticals Market by Route of Administration
10.2.6.1.2 Germany Specialty Pharmaceuticals Market by Therapeutic Area
10.2.6.1.3 Germany Specialty Pharmaceuticals Market by Distribution Channel
10.2.6.2 France Specialty Pharmaceuticals Market
10.2.6.2.1 France Specialty Pharmaceuticals Market by Route of Administration
10.2.6.2.2 France Specialty Pharmaceuticals Market by Therapeutic Area
10.2.6.2.3 France Specialty Pharmaceuticals Market by Distribution Channel
10.2.6.3 Italy Specialty Pharmaceuticals Market
10.2.6.3.1 Italy Specialty Pharmaceuticals Market by Route of Administration
10.2.6.3.2 Italy Specialty Pharmaceuticals Market by Therapeutic Area
10.2.6.3.3 Italy Specialty Pharmaceuticals Market by Distribution Channel
10.2.6.4 Spain Specialty Pharmaceuticals Market
10.2.6.4.1 Spain Specialty Pharmaceuticals Market by Route of Administration
10.2.6.4.2 Spain Specialty Pharmaceuticals Market by Therapeutic Area
10.2.6.4.3 Spain Specialty Pharmaceuticals Market by Distribution Channel
10.2.6.5 United Kingdom Specialty Pharmaceuticals Market
10.2.6.5.1 United Kingdom Specialty Pharmaceuticals Market by Route of Administration
10.2.6.5.2 United Kingdom Specialty Pharmaceuticals Market by Therapeutic Area
10.2.6.5.3 United Kingdom Specialty Pharmaceuticals Market by Distribution Channel
10.2.6.6 Rest of Europe Specialty Pharmaceuticals Market
10.2.6.6.1 Rest of Europe Specialty Pharmaceuticals Market by Route of Administration
10.2.6.6.2 Rest of Europe Specialty Pharmaceuticals Market by Therapeutic Area
10.2.6.6.3 Rest of Europe Specialty Pharmaceuticals Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Specialty Pharmaceuticals Market Overview
10.3.2 Asia-Pacific Specialty Pharmaceuticals Market Forecasts and Analysis
10.3.3 Asia-Pacific Specialty Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
10.3.4 Asia-Pacific Specialty Pharmaceuticals Market Forecasts and Analysis - By Therapeutic Area
10.3.5 Asia-Pacific Specialty Pharmaceuticals Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Specialty Pharmaceuticals Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Specialty Pharmaceuticals Market
10.3.6.1.1 Australia Specialty Pharmaceuticals Market by Route of Administration
10.3.6.1.2 Australia Specialty Pharmaceuticals Market by Therapeutic Area
10.3.6.1.3 Australia Specialty Pharmaceuticals Market by Distribution Channel
10.3.6.2 China Specialty Pharmaceuticals Market
10.3.6.2.1 China Specialty Pharmaceuticals Market by Route of Administration
10.3.6.2.2 China Specialty Pharmaceuticals Market by Therapeutic Area
10.3.6.2.3 China Specialty Pharmaceuticals Market by Distribution Channel
10.3.6.3 India Specialty Pharmaceuticals Market
10.3.6.3.1 India Specialty Pharmaceuticals Market by Route of Administration
10.3.6.3.2 India Specialty Pharmaceuticals Market by Therapeutic Area
10.3.6.3.3 India Specialty Pharmaceuticals Market by Distribution Channel
10.3.6.4 Japan Specialty Pharmaceuticals Market
10.3.6.4.1 Japan Specialty Pharmaceuticals Market by Route of Administration
10.3.6.4.2 Japan Specialty Pharmaceuticals Market by Therapeutic Area
10.3.6.4.3 Japan Specialty Pharmaceuticals Market by Distribution Channel
10.3.6.5 South Korea Specialty Pharmaceuticals Market
10.3.6.5.1 South Korea Specialty Pharmaceuticals Market by Route of Administration
10.3.6.5.2 South Korea Specialty Pharmaceuticals Market by Therapeutic Area
10.3.6.5.3 South Korea Specialty Pharmaceuticals Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Specialty Pharmaceuticals Market
10.3.6.6.1 Rest of Asia-Pacific Specialty Pharmaceuticals Market by Route of Administration
10.3.6.6.2 Rest of Asia-Pacific Specialty Pharmaceuticals Market by Therapeutic Area
10.3.6.6.3 Rest of Asia-Pacific Specialty Pharmaceuticals Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Specialty Pharmaceuticals Market Overview
10.4.2 Middle East and Africa Specialty Pharmaceuticals Market Forecasts and Analysis
10.4.3 Middle East and Africa Specialty Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
10.4.4 Middle East and Africa Specialty Pharmaceuticals Market Forecasts and Analysis - By Therapeutic Area
10.4.5 Middle East and Africa Specialty Pharmaceuticals Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Specialty Pharmaceuticals Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Specialty Pharmaceuticals Market
10.4.6.1.1 South Africa Specialty Pharmaceuticals Market by Route of Administration
10.4.6.1.2 South Africa Specialty Pharmaceuticals Market by Therapeutic Area
10.4.6.1.3 South Africa Specialty Pharmaceuticals Market by Distribution Channel
10.4.6.2 Saudi Arabia Specialty Pharmaceuticals Market
10.4.6.2.1 Saudi Arabia Specialty Pharmaceuticals Market by Route of Administration
10.4.6.2.2 Saudi Arabia Specialty Pharmaceuticals Market by Therapeutic Area
10.4.6.2.3 Saudi Arabia Specialty Pharmaceuticals Market by Distribution Channel
10.4.6.3 U.A.E Specialty Pharmaceuticals Market
10.4.6.3.1 U.A.E Specialty Pharmaceuticals Market by Route of Administration
10.4.6.3.2 U.A.E Specialty Pharmaceuticals Market by Therapeutic Area
10.4.6.3.3 U.A.E Specialty Pharmaceuticals Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Specialty Pharmaceuticals Market
10.4.6.4.1 Rest of Middle East and Africa Specialty Pharmaceuticals Market by Route of Administration
10.4.6.4.2 Rest of Middle East and Africa Specialty Pharmaceuticals Market by Therapeutic Area
10.4.6.4.3 Rest of Middle East and Africa Specialty Pharmaceuticals Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Specialty Pharmaceuticals Market Overview
10.5.2 South and Central America Specialty Pharmaceuticals Market Forecasts and Analysis
10.5.3 South and Central America Specialty Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
10.5.4 South and Central America Specialty Pharmaceuticals Market Forecasts and Analysis - By Therapeutic Area
10.5.5 South and Central America Specialty Pharmaceuticals Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Specialty Pharmaceuticals Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Specialty Pharmaceuticals Market
10.5.6.1.1 Brazil Specialty Pharmaceuticals Market by Route of Administration
10.5.6.1.2 Brazil Specialty Pharmaceuticals Market by Therapeutic Area
10.5.6.1.3 Brazil Specialty Pharmaceuticals Market by Distribution Channel
10.5.6.2 Argentina Specialty Pharmaceuticals Market
10.5.6.2.1 Argentina Specialty Pharmaceuticals Market by Route of Administration
10.5.6.2.2 Argentina Specialty Pharmaceuticals Market by Therapeutic Area
10.5.6.2.3 Argentina Specialty Pharmaceuticals Market by Distribution Channel
10.5.6.3 Rest of South and Central America Specialty Pharmaceuticals Market
10.5.6.3.1 Rest of South and Central America Specialty Pharmaceuticals Market by Route of Administration
10.5.6.3.2 Rest of South and Central America Specialty Pharmaceuticals Market by Therapeutic Area
10.5.6.3.3 Rest of South and Central America Specialty Pharmaceuticals Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SPECIALTY PHARMACEUTICALS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. SPECIALTY PHARMACEUTICALS MARKET, KEY COMPANY PROFILES
13.1. PFIZER INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AMGEN INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ASTRAZENECA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. OTSUKA AMERICA PHARMACEUTICAL, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. REVO BIOLOGICS, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ABBVIE INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. GILEAD
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. JANSSEN GLOBAL SERVICES, LLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. CELGENE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. Amgen Inc.
3. AstraZeneca
4. Teva Pharmaceutical Industries Ltd.
5. Otsuka America Pharmaceutical, Inc.
6. rEVO Biologics, Inc.
7. AbbVie Inc.
8. Gilead
9. Janssen Global Services, LLC
10. Celgene
11. Ginger.io.
12. Lonza
13. ObsEva
14. Zealand Pharma
15. Polyphor
16. Aclaris Therapeutics
17. Allergan
18. Supernus Pharma
19. Taiho Pharmaceutical
20. AMAG Pharmaceuticals, Inc.
TIPRE00021699
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount